Esperion Therapeutics's three largest insider shareholders as of June 09, 2026 are Benjamin Halladay (Chief Financial Officer, 713.60K shares), Benjamin Looker (Chief Legal Officer, 679.35K shares), John B. Jr. Harlow (Chief Commercial Officer, 424.54K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Antonio M Jr Md D Phil Gotto | - | 51,599 | 0 | 23 May, 2024 |
| Robert E. Hoffman | - | 5,280 | 0 | 02 Jun, 2025 |
| Nicole Vitullo | - | 36,918 | 0 | 16 Jun, 2023 |
| Stephen Rocamboli | - | 69,261 | 0 | 02 Jun, 2025 |
| J Martin Carroll | - | 97,650 | 0 | 02 Jun, 2025 |
| Seth H. Z. Fischer | - | 61,150 | 0 | 02 Jun, 2025 |
| Jay Shepard | - | 84,599 | 0 | 02 Jun, 2025 |
| Tracy M Woody | - | 33,566 | 0 | 16 Jun, 2023 |
| Richard Bartram | Chief Financial Officer | 82,751 | 0 | 16 Mar, 2022 |
| Benjamin Looker | Chief Legal Officer | 679,348 | 0 | 18 Mar, 2026 |
| Joanne M. Foody | Chief Medical Officer | 272,862 | 0 | 18 Jul, 2024 |
| Eric Warren | Chief Commercial Officer | 370,218 | 0 | 21 Apr, 2025 |
| Benjamin Halladay | Chief Financial Officer | 713,602 | 0 | 18 Mar, 2026 |
| John B. Jr. Harlow | Chief Commercial Officer | 424,536 | 0 | 08 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Mar, 2026 | Benjamin Halladay | Common Stock | D | 6,424 | $2.71 | 713,602 | D | S |
| 17 Mar, 2026 | Benjamin Halladay | Common Stock | D | 6,424 | $2.71 | 713,602 | D | S |
| 17 Mar, 2026 | Benjamin Looker | Common Stock | D | 5,708 | $2.70 | 679,348 | D | S |
| 13 Mar, 2026 | Benjamin Halladay | Common Stock | A | 247,430 | $0.00 | 720,026 | D | A |
| 13 Mar, 2026 | Benjamin Looker | Common Stock | A | 300,840 | $0.00 | 685,056 | D | A |
| 13 Mar, 2026 | Benjamin Halladay | Common Stock | A | 247,430 | $0.00 | 720,026 | D | A |
| 13 Mar, 2026 | Benjamin Looker | Stock Option (right to buy) | A | 269,230 | $0.00 | 269,230 | D | A |
| 13 Mar, 2026 | Benjamin Halladay | Stock Option (right to buy) | A | 221,270 | $0.00 | 221,270 | D | A |
| 13 Mar, 2026 | Benjamin Halladay | Stock Option (right to buy) | A | 221,270 | $0.00 | 221,270 | D | A |
| 20 Jan, 2026 | Benjamin Looker | Common Stock | D | 1,689 | $2.88 | 384,216 | D | S |
| 17 Dec, 2025 | Benjamin Halladay | Common Stock | D | 7,337 | $3.67 | 467,525 | D | S |
| 17 Dec, 2025 | Benjamin Halladay | Common Stock | D | 7,337 | $3.67 | 467,525 | D | S |
| 17 Dec, 2025 | Benjamin Looker | Common Stock | D | 6,517 | $3.67 | 385,905 | D | S |
| 04 Dec, 2025 | John B. Jr. Harlow | Common Stock | A | 424,536 | $0.00 | 424,536 | D | A |
| 04 Dec, 2025 | John B. Jr. Harlow | Common Stock | A | 424,536 | $0.00 | 424,536 | D | A |
| 04 Dec, 2025 | John B. Jr. Harlow | Stock Option (right to buy) | A | 380,000 | $0.00 | 380,000 | D | A |
| 04 Dec, 2025 | John B. Jr. Harlow | Stock Option (right to buy) | A | 380,000 | $0.00 | 380,000 | D | A |
| 17 Oct, 2025 | Benjamin Looker | Common Stock | D | 1,248 | $2.62 | 392,422 | D | S |
| 17 Sep, 2025 | Benjamin Halladay | Common Stock | D | 7,046 | $2.81 | 474,862 | D | S |
| 17 Sep, 2025 | Benjamin Looker | Common Stock | D | 6,267 | $2.80 | 393,670 | D | S |